person · Reporting owner

Hoffman Reid

Disclosed activity across 6 companies

Tapewire entity: 10683
SEC CIK: 0001519339

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Aurora Innovation, Inc.AUR · Entity 3489	Director	May 28, 2026	May 28, 2026
MICROSOFT CORPMSFT · Entity 1016	Director	September 10, 2026	September 11, 2026
Vor Biopharma Inc.VOR · Entity 4763	10% owner	October 17, 2025	October 21, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Aurora Innovation, Inc.

Report date May 28, 2026 · Filed May 28, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	0	Reported balance After 2026-05-28 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2026-05-28 · Sale · Disposed 1,082,118 · Balance 0 F1: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.08 to $7.3850 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3: Reflects securities held directly by Greylock 15.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	0	Reported balance After 2026-05-28 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2026-05-28 · Sale · Disposed 60,118 · Balance 0 F1: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.08 to $7.3850 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4: Reflects securities held directly by Greylock 15-A.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	0	Reported balance After 2026-05-28 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2026-05-28 · Sale · Disposed 60,118 · Balance 0 F1: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.08 to $7.3850 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5: Reflects securities held directly by Greylock 15 Principals.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnote	5,162,315	Reported balance Holding disclosure · report date 2026-05-28 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 5,162,315 F6: Reflects securities held directly by Reinvent Sponsor Y LLC (the "Sponsor"). The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnote	1,550,646	Reported balance Holding disclosure · report date 2026-05-28 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 1,550,646 F7: Reflects securities held by Reprogrammed Interchange LLC ("Reprogrammed"). The reporting person may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. The reporting person disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnote	674,719	Reported balance Holding disclosure · report date 2026-05-28 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 674,719 F8: Reflects securities held by Programmable Exchange LLC ("Programmable"). The reporting person may be deemed a beneficial owner of securities held by Programmable by virtue of his voting and investment power over such securities. The reporting person disclaims beneficial ownership of the securities held by Programmable, except to the extent of his pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	Direct	354,669	Reported balance Holding disclosure · report date 2026-05-28 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 354,669

Filing footnotes · ownership attribution and instrument terms

F1: Weighted average price. This transaction was executed in multiple trades at prices ranging from $7.08 to $7.3850 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein.

F3: Reflects securities held directly by Greylock 15.

F4: Reflects securities held directly by Greylock 15-A.

F5: Reflects securities held directly by Greylock 15 Principals.

F6: Reflects securities held directly by Reinvent Sponsor Y LLC (the "Sponsor"). The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein.

F7: Reflects securities held by Reprogrammed Interchange LLC ("Reprogrammed"). The reporting person may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. The reporting person disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

F8: Reflects securities held by Programmable Exchange LLC ("Programmable"). The reporting person may be deemed a beneficial owner of securities held by Programmable by virtue of his voting and investment power over such securities. The reporting person disclaims beneficial ownership of the securities held by Programmable, except to the extent of his pecuniary interest therein.

MICROSOFT CORP

Report date September 10, 2026 · Filed September 11, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	17,182.471	Reported balance After 2026-09-10 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-09-10 · Grant · Acquired 31.692 · Balance 17,182.471 F1: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate. F3: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors.
Common StockSEC Table I · non-derivative	IndirectBy Living Trust	15,905	Reported balance Holding disclosure · report date 2026-09-10 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 15,905

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock.

F2: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate.

F3: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors.

Vor Biopharma Inc.

Report date October 17, 2025 · Filed October 21, 2025

Jointly reported with Reprogrammed Interchange LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,166,909	Last balance in matching sequence After 2025-10-21 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 4 source rows Row 1 · 2025-10-17 · Sale · Disposed 24,689 · Balance 1,179,753 F1: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Row 2 · 2025-10-17 · Sale · Disposed 1,028 · Balance 1,178,725 F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Row 3 · 2025-10-20 · Sale · Disposed 11,616 · Balance 1,167,109 F3: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Row 4 · 2025-10-21 · Sale · Disposed 200 · Balance 1,166,909 F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

F3: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Hippo Holdings Inc.

Report date August 02, 2021 · Filed August 03, 2021

Section 16 reporting ended · disclosed 2021-08-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnote	5,630,000	Reported balance After 2021-08-02 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2021-08-02 · Exercise / conversion · Acquired 5,630,000 · Balance 5,630,000 F1: 75% of such shares are subject to vesting in tranches of 25% if the volume weighted average price of the Issuer's shares of Common Stock equals or exceeds $12.50, $15.00, or $20.00, respectively, for any 20 trading days within a 30 trading day period on or prior to the tenth anniversary of the business combination of Reinvent Technology Partners Z (the former name of the Issuer) ("RTPZ") and Hippo Enterprises Inc. (the "Business Combination"). On August 2, 2031, any unvested shares will automatically vest. In the event the Issuer completes a transaction that results in a change of control, all unvested shares will vest immediately prior to the closing of such transaction. F2: On August 2, 2021, RTPZ consummated the Business Combination. Pursuant to the Business Combination, RTPZ domesticated as a Delaware corporation and changed its name to "Hippo Holdings, Inc.", and each RTPZ Class B ordinary share was automatically converted into the right to receive one share of the Issuer's common stock. The reporting person resigned as a director of the Issuer upon consummation of the Business Combination. F3: The securities reported herein are directly held by Reinvent Sponsor Z LLC (the "Sponsor"). The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein.
Class B ordinary sharesSEC Table II · derivative / convertible security	IndirectSee Footnote	0	Reported balance After 2021-08-02 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-08-02 · Exercise / conversion · Disposed 5,630,000 · Balance 0 F2: On August 2, 2021, RTPZ consummated the Business Combination. Pursuant to the Business Combination, RTPZ domesticated as a Delaware corporation and changed its name to "Hippo Holdings, Inc.", and each RTPZ Class B ordinary share was automatically converted into the right to receive one share of the Issuer's common stock. The reporting person resigned as a director of the Issuer upon consummation of the Business Combination. F3: The securities reported herein are directly held by Reinvent Sponsor Z LLC (the "Sponsor"). The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: 75% of such shares are subject to vesting in tranches of 25% if the volume weighted average price of the Issuer's shares of Common Stock equals or exceeds $12.50, $15.00, or $20.00, respectively, for any 20 trading days within a 30 trading day period on or prior to the tenth anniversary of the business combination of Reinvent Technology Partners Z (the former name of the Issuer) ("RTPZ") and Hippo Enterprises Inc. (the "Business Combination"). On August 2, 2031, any unvested shares will automatically vest. In the event the Issuer completes a transaction that results in a change of control, all unvested shares will vest immediately prior to the closing of such transaction.

F2: On August 2, 2021, RTPZ consummated the Business Combination. Pursuant to the Business Combination, RTPZ domesticated as a Delaware corporation and changed its name to "Hippo Holdings, Inc.", and each RTPZ Class B ordinary share was automatically converted into the right to receive one share of the Issuer's common stock. The reporting person resigned as a director of the Issuer upon consummation of the Business Combination.

F3: The securities reported herein are directly held by Reinvent Sponsor Z LLC (the "Sponsor"). The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein.

Joby Aviation, Inc.

Report date June 14, 2024 · Filed June 19, 2024

Section 16 reporting ended · disclosed 2024-06-19. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	102,603	Reported balance After 2024-06-14 transaction · row 1 1 source row Row 1 · 2024-06-14 · Exercise / conversion · Acquired 22,556 · Balance 102,603
Restricted Stock Units (RSUs)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2024-06-14 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2024-06-14 · Exercise / conversion · Disposed 22,556 · Balance 0 F3: Represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors (the "Annual Award"). The Annual Award shall fully vest on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) June 22, 2024, in each case, subject to Reporting Person's continued status as a Service Provider (as defined in the Issuer's 2021 Incentive Award Plan) through the applicable vesting date. Each RSU represents a contingent right to receive one share of Common Stock upon vesting.
Common StockSEC Table I · non-derivative	IndirectBy Reinvent Sponsor LLC	17,130,000	Reported balance Holding disclosure · report date 2024-06-14 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 17,130,000 F1: The securities are directly held by Reinvent Sponsor LLC ("Sponsor"). The Reporting Person may be deemed a beneficial owner of securities held by Sponsor by virtue of his shared control over and indirect pecuniary interest in Sponsor. The Reporting Person disclaims beneficial ownership of the securities held by Sponsor, except to the extent of his pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Reprogrammed Interchange LLC	2,000,000	Reported balance Holding disclosure · report date 2024-06-14 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 2,000,000 F2: These securities are directly held by Reprogrammed Interchange LLC ("Reprogrammed"). On the basis of the Reporting Person's relationship with Reprogrammed, the Reporting Person may be deemed a beneficial owners of the securities held by Reprogrammed. The Reporting Person disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The securities are directly held by Reinvent Sponsor LLC ("Sponsor"). The Reporting Person may be deemed a beneficial owner of securities held by Sponsor by virtue of his shared control over and indirect pecuniary interest in Sponsor. The Reporting Person disclaims beneficial ownership of the securities held by Sponsor, except to the extent of his pecuniary interest therein.

F2: These securities are directly held by Reprogrammed Interchange LLC ("Reprogrammed"). On the basis of the Reporting Person's relationship with Reprogrammed, the Reporting Person may be deemed a beneficial owners of the securities held by Reprogrammed. The Reporting Person disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

F3: Represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors (the "Annual Award"). The Annual Award shall fully vest on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) June 22, 2024, in each case, subject to Reporting Person's continued status as a Service Provider (as defined in the Issuer's 2021 Incentive Award Plan) through the applicable vesting date. Each RSU represents a contingent right to receive one share of Common Stock upon vesting.

LINKEDIN CORP

Report date August 17, 2016 · Filed December 09, 2016

Jointly reported with Reid Hoffman & Michelle Yee Living Trust

Section 16 reporting ended · disclosed 2016-12-09. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	0	Last balance in matching sequence After 2016-08-17 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2016-08-17 · Conversion · Acquired 900,000 · Balance 900,000 F1: 900,000 shares of Class B Common Stock were converted into 900,000 shares of Class A Common Stock at the election of the Reporting Person and had no expiration date. F2: Shares held directly by the Reid Hoffman and Michelle Yee Living Trust dated October 27, 2009 for which Mr. Hoffman and his spouse serve as trustees (the "Living Trust"). Mr. Hoffman retains sole voting and dispositive power with respect to the shares held by the Living Trust. Row 2 · 2016-08-17 · Gift · Disposed 900,000 · Balance 0 F2: Shares held directly by the Reid Hoffman and Michelle Yee Living Trust dated October 27, 2009 for which Mr. Hoffman and his spouse serve as trustees (the "Living Trust"). Mr. Hoffman retains sole voting and dispositive power with respect to the shares held by the Living Trust.
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnote	13,589,899	Reported balance After 2016-08-17 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2016-08-17 · Conversion · Disposed 900,000 · Balance 13,589,899 F1: 900,000 shares of Class B Common Stock were converted into 900,000 shares of Class A Common Stock at the election of the Reporting Person and had no expiration date. F2: Shares held directly by the Reid Hoffman and Michelle Yee Living Trust dated October 27, 2009 for which Mr. Hoffman and his spouse serve as trustees (the "Living Trust"). Mr. Hoffman retains sole voting and dispositive power with respect to the shares held by the Living Trust.
Class B Common StockSEC Table II · derivative / convertible security	IndirectSee footnote	0	Reported balance After 2016-12-08 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2016-12-08 · Disposition to issuer · Disposed 13,589,899 · Balance 0 F3: The shares of Class B Common Stock were cancelled pursuant to the Agreement and Plan of Merger, dated June 11, 2016, between the Issuer, Microsoft Corporation and Liberty Merger Sub Inc. (the "Merger Agreement") in exchange for a cash payment of $196 per share (the "Merger Consideration") and had no expiration date. F4: Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration. F2: Shares held directly by the Reid Hoffman and Michelle Yee Living Trust dated October 27, 2009 for which Mr. Hoffman and his spouse serve as trustees (the "Living Trust"). Mr. Hoffman retains sole voting and dispositive power with respect to the shares held by the Living Trust.

Filing footnotes · ownership attribution and instrument terms

F1: 900,000 shares of Class B Common Stock were converted into 900,000 shares of Class A Common Stock at the election of the Reporting Person and had no expiration date.

F2: Shares held directly by the Reid Hoffman and Michelle Yee Living Trust dated October 27, 2009 for which Mr. Hoffman and his spouse serve as trustees (the "Living Trust"). Mr. Hoffman retains sole voting and dispositive power with respect to the shares held by the Living Trust.

F3: The shares of Class B Common Stock were cancelled pursuant to the Agreement and Plan of Merger, dated June 11, 2016, between the Issuer, Microsoft Corporation and Liberty Merger Sub Inc. (the "Merger Agreement") in exchange for a cash payment of $196 per share (the "Merger Consideration") and had no expiration date.

F4: Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 02, 2025 Filed Oct 3, 2025 21:12 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	4,937	$37.21	$183,684.54	Disclosure SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,632,723 F4 · price: This transaction was executed in multiple trades at prices ranging from $36.82 to $37.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
October 01, 2025 Filed Oct 3, 2025 21:12 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	1,400	$39.19	$54,869.50	Disclosure SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,637,660 F1 · price: This transaction was executed in multiple trades at prices ranging from $39.11 to $39.415. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The number of shares beneficially owned reflects the 1-for-20 reverse stock split effected September 18, 2025. F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
September 16, 2025 Filed Sep 18, 2025 20:40 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	447,278	$1.54	$688,852.85	Disclosure SEC source: 0002050755-25-000008 · form4-09192025_120912.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,781,209 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.52 to $1.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
September 15, 2025 Filed Sep 15, 2025 17:17 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	400,000	$1.64	$656,320.00	Disclosure SEC source: 0002050755-25-000007 · form4-09152025_090921.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,228,487 F4 · price: This transaction was executed in multiple trades at prices ranging from $1.57 to $1.765. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
September 12, 2025 Filed Sep 15, 2025 17:17 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	300,000	$1.75	$526,230.00	Disclosure SEC source: 0002050755-25-000007 · form4-09152025_090921.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,628,487 F3 · price: This transaction was executed in multiple trades at prices ranging from $1.73 to $1.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
September 11, 2025 Filed Sep 15, 2025 17:17 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	284,805	$1.83	$521,420.99	Disclosure SEC source: 0002050755-25-000007 · form4-09152025_090921.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,928,487 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.81 to $1.855. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
September 11, 2025 Filed Sep 12, 2025 22:04 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	26.821	$0.00	$0.00	Disclosure SEC source: 0000789019-25-000033 · form4.xml · derivative · entry 3 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,217.251 Underlying: Common Stock · 26.821 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F3 · shares: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate. F2 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F2 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
September 10, 2025 Filed Sep 10, 2025 20:27 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	350,000	$1.82	$635,285.00	Disclosure SEC source: 0001415889-25-024198 · form4-09112025_120901.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,213,292 F4 · price: This transaction was executed in multiple trades at prices ranging from $1.80 to $1.935. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
September 10, 2025 Filed Sep 12, 2025 22:04 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	187.361	$0.00	$0.00	Disclosure SEC source: 0000789019-25-000033 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,190.43 Underlying: Common Stock · 187.361 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F2 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
September 09, 2025 Filed Sep 10, 2025 20:27 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	449,226	$2.00	$898,631.69	Disclosure SEC source: 0001415889-25-024198 · form4-09112025_120901.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,563,292 F3 · price: This transaction was executed in multiple trades at prices ranging from $1.97 to $2.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
September 08, 2025 Filed Sep 10, 2025 20:27 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	464,421	$1.99	$924,058.46	Disclosure SEC source: 0001415889-25-024198 · form4-09112025_120901.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,012,518 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.97 to $2.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
September 05, 2025 Filed Sep 5, 2025 18:51 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	400,000	$1.97	$787,280.00	Disclosure SEC source: 0001415889-25-023821 · form4-09052025_100921.xml · nonDerivative · entry 3 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,476,939 F4 · price: This transaction was executed in multiple trades at prices ranging from $1.935 to $1.995. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
September 04, 2025 Filed Sep 5, 2025 18:51 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	453,016	$1.93	$873,641.36	Disclosure SEC source: 0001415889-25-023821 · form4-09052025_100921.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,876,939 F3 · price: This transaction was executed in multiple trades at prices ranging from $1.91 to $2.005. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
September 03, 2025 Filed Sep 5, 2025 18:51 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	554,612	$2.00	$1,107,061.01	Disclosure SEC source: 0001415889-25-023821 · form4-09052025_100921.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,329,955 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.99 to $2.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
August 28, 2025 Filed Aug 29, 2025 18:05 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	806,351	$2.01	$1,621,975.04	Disclosure SEC source: 0001415889-25-023318 · form4-08292025_100808.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,884,567 F3 · price: This transaction was executed in multiple trades at prices ranging from $1.95 to $2.075. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
August 27, 2025 Filed Aug 29, 2025 18:05 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	611,647	$2.01	$1,226,535.73	Disclosure SEC source: 0001415889-25-023318 · form4-08292025_100808.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,690,918 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.99 to $2.10. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
August 26, 2025 Filed Aug 27, 2025 17:25 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	284,190	$2.08	$591,342.55	Disclosure SEC source: 0001415889-25-023165 · form4-08272025_090848.xml · nonDerivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,302,565 F3 · price: This transaction was executed in multiple trades at prices ranging from $2.06 to $2.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
August 25, 2025 Filed Aug 27, 2025 17:25 UTC	Vor Biopharma Inc. VOR · Entity 4763	SaleCommon Stock	387,346	$2.12	$819,740.34	Disclosure SEC source: 0001415889-25-023165 · form4-08272025_090848.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,586,755 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.05 to $2.215. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
June 12, 2025 Filed Jun 13, 2025 22:00 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	27.689	$0.00	$0.00	Disclosure SEC source: 0001062993-25-011698 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,003.069 Underlying: Common Stock · 27.689 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · shares: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F3 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
June 10, 2025 Filed Jun 11, 2025 22:05 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	199.078	$0.00	$0.00	Disclosure SEC source: 0001062993-25-011450 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,975.38 Underlying: Common Stock · 199.078 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F2 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
May 22, 2025 Filed May 22, 2025 16:32 UTC	Aurora Innovation, Inc. AUR · Entity 3489	GrantClass A Common Stock	31,875	$0.00	$0.00	Disclosure SEC source: 0001828108-25-000112 · wk-form4_1747945941.xml · nonDerivative · entry 1 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,122 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. 100% of the RSUs will vest on the earlier of (i) May 22, 2026 or (ii) the day prior to the date of the Issuer's next annual stockholders meeting following May 22, 2025, in each case, subject to the reporting person's continued service through the applicable vesting date. Read SEC document
March 13, 2025 Filed Mar 14, 2025 22:06 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	34.493	$0.00	$0.00	Disclosure SEC source: 0001062993-25-005509 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,776.302 Underlying: Common Stock · 34.493 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · shares: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F3 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
February 21, 2025 Filed Feb 21, 2025 20:51 UTC	Aurora Innovation, Inc. AUR · Entity 3489	OtherPrivate Placement Warrants · Derivative	2,848,000	$0.00 Strike: $11.50	$0.00	Disclosure SEC source: 0001828108-25-000043 · wk-form4_1740189065.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,848,000 Underlying: Class A Common Stock · 2,848,000 shares Expires 2026-11-03 F1 · kind: On February 21, 2025, Reinvent Sponsor Y LLC (the "Sponsor") declared a distribution of 8,900,000 private placement warrants to its direct and indirect members for no consideration, with such distribution to be effective three trading days thereafter. Reprogrammed Interchange LLC ("Reprogrammed") will receive, directly and indirectly, 2,848,000 of the private placement warrants to be distributed by the Sponsor and will own those warrants directly upon effectiveness of the distribution. F3 · ownership.nature: Reflects securities held by Reprogrammed. The reporting person may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. The reporting person disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
February 21, 2025 Filed Feb 21, 2025 20:51 UTC	Aurora Innovation, Inc. AUR · Entity 3489	OtherPrivate Placement Warrants · Derivative	8,900,000	$0.00 Strike: $11.50	$0.00	Disclosure SEC source: 0001828108-25-000043 · wk-form4_1740189065.xml · derivative · entry 1 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 8,900,000 shares Expires 2026-11-03 F1 · kind: On February 21, 2025, Reinvent Sponsor Y LLC (the "Sponsor") declared a distribution of 8,900,000 private placement warrants to its direct and indirect members for no consideration, with such distribution to be effective three trading days thereafter. Reprogrammed Interchange LLC ("Reprogrammed") will receive, directly and indirectly, 2,848,000 of the private placement warrants to be distributed by the Sponsor and will own those warrants directly upon effectiveness of the distribution. F2 · ownership.nature: Reflects securities held directly by the Sponsor. The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein. Read SEC document
February 18, 2025 Filed Feb 20, 2025 18:36 UTC	Aurora Innovation, Inc. AUR · Entity 3489	OtherClass A Common Stock	550,646	$0.00	$0.00	Disclosure SEC source: 0001828108-25-000037 · wk-form4_1740094569.xml · nonDerivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,550,646 F1 · kind: On February 18, 2025, Reinvent Sponsor Y LLC (the "Sponsor") distributed 1,720,771 shares of the issuer's Class A common stock to its direct and indirect members for no consideration. Reprogrammed Interchange LLC ("Reprogrammed") indirectly received 550,646 of the shares distributed by the Sponsor and now owns those shares directly. F3 · ownership.nature: Reflects securities held by Reprogrammed. The reporting person may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. The reporting person disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
February 18, 2025 Filed Feb 20, 2025 18:36 UTC	Aurora Innovation, Inc. AUR · Entity 3489	OtherClass A Common Stock	1,720,771	$0.00	$0.00	Disclosure SEC source: 0001828108-25-000037 · wk-form4_1740094569.xml · nonDerivative · entry 1 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,162,315 F1 · kind: On February 18, 2025, Reinvent Sponsor Y LLC (the "Sponsor") distributed 1,720,771 shares of the issuer's Class A common stock to its direct and indirect members for no consideration. Reprogrammed Interchange LLC ("Reprogrammed") indirectly received 550,646 of the shares distributed by the Sponsor and now owns those shares directly. F2 · ownership.nature: Reflects securities held directly by the Sponsor. The reporting person may be deemed a beneficial owner of securities held by the Sponsor by virtue of his shared control over and indirect pecuniary interest in the Sponsor. The reporting person disclaims beneficial ownership of the securities held by the Sponsor, except to the extent of his pecuniary interest therein. Read SEC document
January 31, 2025 Filed Feb 3, 2025 23:02 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	225.871	$0.00	$0.00	Disclosure SEC source: 0001062993-25-001517 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,741.808 Underlying: Common Stock · 225.871 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F2 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
December 30, 2024 Filed Jan 2, 2025 19:42 UTC	Vor Biopharma Inc. VOR · Entity 4763	PurchaseWarrant (Right to Buy) · Derivative	48,717,626	Not disclosed Strike: $0.84	Not disclosed	Disclosure SEC source: 0001415889-25-000220 · form4-01032025_120101.xml · derivative · entry 2 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,717,626 Underlying: Common Stock · 48,717,626 shares Expires 2031-12-30 F1 · price: Each share of Common Stock was purchased together with an accompanying Warrant to purchase 1.25 shares of Common Stock. The purchase price of the securities was $0.99425 per share and accompanying Warrant. F3 · derivative.exercise_date: The Warrants are exercisable immediately. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Warrants to the extent that such exercise would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Person, their affiliates and any persons who are members of a Section 13(d) group with the Reporting Persons or their affiliates to exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
December 30, 2024 Filed Jan 2, 2025 19:42 UTC	Vor Biopharma Inc. VOR · Entity 4763	PurchaseCommon Stock	38,974,101	Not disclosed	Not disclosed	Disclosure SEC source: 0001415889-25-000220 · form4-01032025_120101.xml · nonDerivative · entry 1 Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner Hoffman Reid · CIK 0001519339 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,974,101 F1 · price: Each share of Common Stock was purchased together with an accompanying Warrant to purchase 1.25 shares of Common Stock. The purchase price of the securities was $0.99425 per share and accompanying Warrant. F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. Read SEC document
December 12, 2024 Filed Dec 13, 2024 23:04 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	28.593	$0.00	$0.00	Disclosure SEC source: 0001062993-24-020617 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,515.937 Underlying: Common Stock · 28.593 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · shares: Dividend equivalent rights accrue when and as dividends are paid on the Company's common stock and become exercisable proportionately with the restricted stock units to which they relate. F3 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F3 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
December 09, 2024 Filed Dec 10, 2024 23:11 UTC	MICROSOFT CORP MSFT · Entity 1016	GrantRestricted Stock Units · Derivative	201.785	$0.00	$0.00	Disclosure SEC source: 0001062993-24-020387 · form4.xml · derivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,487.344 Underlying: Common Stock · 201.785 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Microsoft common stock. F2 · derivative.exercise_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. F2 · derivative.expiration_date: The restricted stock units are fully vested. Delivery of the shares to the reporting person will be made on the 1st anniversary after the date of the reporting person's separation from service to the Board of Directors. Read SEC document
November 18, 2024 Filed Nov 18, 2024 17:11 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	26,892	$5.48	$147,459.59	Disclosure SEC source: 0001828108-24-000151 · wk-form4_1731967881.xml · nonDerivative · entry 3 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.24 to $5.70, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects securities held directly by Greylock 15 Principals. Read SEC document
November 18, 2024 Filed Nov 18, 2024 17:11 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	26,892	$5.48	$147,459.59	Disclosure SEC source: 0001828108-24-000151 · wk-form4_1731967881.xml · nonDerivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.24 to $5.70, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4 · ownership.nature: Reflects securities held directly by Greylock 15-A. Read SEC document
November 18, 2024 Filed Nov 18, 2024 17:11 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	484,053	$5.48	$2,654,256.22	Disclosure SEC source: 0001828108-24-000151 · wk-form4_1731967881.xml · nonDerivative · entry 1 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.24 to $5.70, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects securities held directly by Greylock 15. Read SEC document
November 15, 2024 Filed Nov 15, 2024 17:24 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	22,352	$5.04	$112,701.02	Disclosure SEC source: 0001828108-24-000149 · wk-form4_1731709486.xml · nonDerivative · entry 9 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 26,892 F7 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.00 to $5.27, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects securities held directly by Greylock 15 Principals. Read SEC document
November 15, 2024 Filed Nov 15, 2024 17:24 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	22,352	$5.04	$112,701.02	Disclosure SEC source: 0001828108-24-000149 · wk-form4_1731709486.xml · nonDerivative · entry 8 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 26,892 F7 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.00 to $5.27, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4 · ownership.nature: Reflects securities held directly by Greylock 15-A. Read SEC document
November 15, 2024 Filed Nov 15, 2024 17:24 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	402,342	$5.04	$2,028,648.60	Disclosure SEC source: 0001828108-24-000149 · wk-form4_1731709486.xml · nonDerivative · entry 7 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 484,053 F7 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.00 to $5.27, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects securities held directly by Greylock 15. Read SEC document
November 14, 2024 Filed Nov 15, 2024 17:24 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	75,756	$5.37	$407,021.84	Disclosure SEC source: 0001828108-24-000149 · wk-form4_1731709486.xml · nonDerivative · entry 6 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 49,244 F6 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.22 to $5.49, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects securities held directly by Greylock 15 Principals. Read SEC document
November 14, 2024 Filed Nov 15, 2024 17:24 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	75,756	$5.37	$407,021.84	Disclosure SEC source: 0001828108-24-000149 · wk-form4_1731709486.xml · nonDerivative · entry 5 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 49,244 F6 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.22 to $5.49, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4 · ownership.nature: Reflects securities held directly by Greylock 15-A. Read SEC document
November 14, 2024 Filed Nov 15, 2024 17:24 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	1,363,605	$5.37	$7,326,376.94	Disclosure SEC source: 0001828108-24-000149 · wk-form4_1731709486.xml · nonDerivative · entry 4 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 886,395 F6 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.22 to $5.49, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects securities held directly by Greylock 15. Read SEC document
November 13, 2024 Filed Nov 15, 2024 17:24 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	59,070	$5.60	$330,886.51	Disclosure SEC source: 0001828108-24-000149 · wk-form4_1731709486.xml · nonDerivative · entry 3 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 125,000 F1 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.205 to $5.805, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects securities held directly by Greylock 15 Principals. Read SEC document
November 13, 2024 Filed Nov 15, 2024 17:24 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	59,070	$5.60	$330,886.51	Disclosure SEC source: 0001828108-24-000149 · wk-form4_1731709486.xml · nonDerivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 125,000 F1 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.205 to $5.805, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4 · ownership.nature: Reflects securities held directly by Greylock 15-A. Read SEC document
November 13, 2024 Filed Nov 15, 2024 17:24 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	1,063,260	$5.60	$5,955,957.22	Disclosure SEC source: 0001828108-24-000149 · wk-form4_1731709486.xml · nonDerivative · entry 1 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 2,250,000 F1 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.205 to $5.805, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects securities held directly by Greylock 15. Read SEC document
November 12, 2024 Filed Nov 12, 2024 20:51 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	84,029	$5.37	$451,008.85	Disclosure SEC source: 0001828108-24-000147 · wk-form4_1731462659.xml · nonDerivative · entry 6 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 184,070 F6 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.22 to $5.47, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects securities held directly by Greylock 15 Principals. Read SEC document
November 12, 2024 Filed Nov 12, 2024 20:51 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	84,029	$5.37	$451,008.85	Disclosure SEC source: 0001828108-24-000147 · wk-form4_1731462659.xml · nonDerivative · entry 5 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 184,070 F6 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.22 to $5.47, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4 · ownership.nature: Reflects securities held directly by Greylock 15-A. Read SEC document
November 12, 2024 Filed Nov 12, 2024 20:51 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	1,512,519	$5.37	$8,118,143.23	Disclosure SEC source: 0001828108-24-000147 · wk-form4_1731462659.xml · nonDerivative · entry 4 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 3,313,260 F6 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.22 to $5.47, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects securities held directly by Greylock 15. Read SEC document
November 11, 2024 Filed Nov 12, 2024 20:51 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	42,840	$5.49	$234,994.54	Disclosure SEC source: 0001828108-24-000147 · wk-form4_1731462659.xml · nonDerivative · entry 3 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 268,099 F1 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.355 to $5.750, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects securities held directly by Greylock 15 Principals. Read SEC document
November 11, 2024 Filed Nov 12, 2024 20:51 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	42,840	$5.49	$234,994.54	Disclosure SEC source: 0001828108-24-000147 · wk-form4_1731462659.xml · nonDerivative · entry 2 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 268,099 F1 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.355 to $5.750, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F4 · ownership.nature: Reflects securities held directly by Greylock 15-A. Read SEC document
November 11, 2024 Filed Nov 12, 2024 20:51 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	771,117	$5.49	$4,229,885.19	Disclosure SEC source: 0001828108-24-000147 · wk-form4_1731462659.xml · nonDerivative · entry 1 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 4,825,779 F1 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.355 to $5.750, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects securities held directly by Greylock 15. Read SEC document
November 08, 2024 Filed Nov 8, 2024 17:18 UTC	Aurora Innovation, Inc. AUR · Entity 3489	SaleClass A Common Stock	41,486	$5.54	$229,782.66	Disclosure SEC source: 0001828108-24-000145 · wk-form4_1731103992.xml · nonDerivative · entry 9 Hoffman Reid · CIK 0001519339 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 310,939 F7 · price: Weighted average price. This transaction was executed in multiple trades at prices ranging from $5.33 to $5.62, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: Greylock 15 GP LLC ("Greylock LLC") is the general partner of each of Greylock 15 Limited Partnership ("Greylock 15"), Greylock 15 Principals Limited Partnership ("Greylock Principals"), and Greylock 15-A Limited Partnership ("Greylock 15-A"). By virtue of being a managing member of Greylock LLC, the reporting person may be deemed a beneficial owner of the securities held by Greylock 15, Greylock Principals, and Greylock 15-A. The reporting person disclaims beneficial ownership of the securities held by Greylock 15, Greylock Principals, and/or Greylock 15-A, except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects securities held directly by Greylock 15 Principals. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.